The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.
about
Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairmentCompetitive inhibition of TRPV1-calmodulin interaction by vanilloidsRegression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver diseaseTherapy of experimental NASH and fibrosis with galectin inhibitors.Disaccharide binding to galectin-1: free energy calculations and molecular recognition mechanism.Structural aspects of binding of α-linked digalactosides to human galectin-1Structural features for α-galactomannan binding to galectin-1.When galectins recognize glycans: from biochemistry to physiology and back againStructure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.Engineering galectin-glycan interactions for immunotherapy and immunomodulationThe alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domainApplication of NMR methods to the study of the interaction of natural products with biomolecular receptors.Galectin-3 inhibitors: a patent review (2008-present).Solution NMR analyses of the C-type carbohydrate recognition domain of DC-SIGNR protein reveal different binding modes for HIV-derived oligosaccharides and smaller glycan fragmentsRegulatory T cells and potential inmmunotherapeutic targets in lung cancer.Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death.Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.Galectins as Molecular Targets for Therapeutic Intervention.
P2860
Q24235237-95F05A5E-A7F7-4A94-A361-2FA2D7CCC76EQ27713396-4114D39D-0B6E-4F3C-AFD2-FAE62110BBDDQ28534290-AFFB658E-6663-4E6C-848C-0338EECD60B0Q35075568-C1A287D5-099B-4F8C-BB50-0AD1888FEC8FQ35144698-8B119F91-4C93-414F-BE65-3690CEC009CFQ35559685-C44AB5A7-F570-487F-AED9-C4A0BB523AB0Q35779469-FE57A9BD-4594-4116-A185-90D1614EF905Q36196146-736C5AE2-3EC8-4EEB-A43E-E3FBC872222CQ36642433-B087BDF5-1E6F-4F3F-AE96-58F4E6124E2CQ37107168-74860B5A-F321-47FE-925E-479C96B96988Q37287658-80ADF931-01DF-443C-B379-54C65C688672Q37864564-B182B946-BF5D-4DD5-8EB4-885C6CA0E138Q38238525-B76352F6-C008-4FC5-92C2-174D48E4DAB0Q38314675-86DBEBFD-E881-4711-BC2A-DD06A3992168Q38473314-B3545559-0F12-4795-A6D8-B9083299D92AQ40232517-465E922D-BD99-4039-9289-33456D05A080Q41904321-E637C3C7-7735-4693-BAF0-D7E3C9E419A7Q46296067-75D38E3A-D8CE-4A90-AF1B-9BC943863B6AQ55316400-4382DB68-3609-4A1D-B46A-F192A25EB3F8
P2860
The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The carbohydrate-binding domai ...... eractions at the cell surface.
@en
The carbohydrate-binding domai ...... eractions at the cell surface.
@nl
type
label
The carbohydrate-binding domai ...... eractions at the cell surface.
@en
The carbohydrate-binding domai ...... eractions at the cell surface.
@nl
prefLabel
The carbohydrate-binding domai ...... eractions at the cell surface.
@en
The carbohydrate-binding domai ...... eractions at the cell surface.
@nl
P2093
P2860
P356
P1433
P1476
The carbohydrate-binding domai ...... eractions at the cell surface.
@en
P2093
Anatole Klyosov
David Platt
Irina V Nesmelova
Kevin H Mayo
Michelle C Miller
P2860
P304
P356
10.1042/BJ20090265
P407
P577
2009-06-26T00:00:00Z